Literature DB >> 22466831

A case of isoniazid-induced thrombocytopenia: recovery with immunoglobulin therapy.

Eun Ju Lee1, Seung Hun Lee, You Eun Kim, Seung Jun Lee, Yu Ji Cho, Yi Yeong Jeong, Ho Cheol Kim, Jong Deog Lee, Young Sil Hwang.   

Abstract

Treatment for a 51-year-old man with pulmonary tuberculosis was initiated with isoniazid, rifampicin, ethambutol, and pyrazinamide, and discontinued after 3 weeks because of skin rash and itchiness. Isoniazid monotherapy was restarted after 2 weeks. Two days later, the platelet count decreased from 150 to 4×10(3)/mm(3). Despite platelet transfusion and oral corticosteroid treatment, the platelet count did not recover. However, after a 2-day administration of intravenous immunoglobulin, the platelet count recovered to 209×10(3)/mm(3). This report describes a case of isoniazid-induced thrombocytopenia that was reversed with intravenous immunoglobulin, thus highlighting the efficacy of this treatment for this rare condition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22466831     DOI: 10.2169/internalmedicine.51.6296

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Genetic polymorphisms of long noncoding RNA RP11-37B2.1 associate with susceptibility of tuberculosis and adverse events of antituberculosis drugs in west China.

Authors:  Jiajia Song; Tangyuheng Liu; Zhenzhen Zhao; Xuejiao Hu; Qian Wu; Wu Peng; Xuerong Chen; Binwu Ying
Journal:  J Clin Lab Anal       Date:  2019-03-28       Impact factor: 2.352

2.  Clinical and genetic analysis of 2 rare cases of Wiskott-Aldrich syndrome from Chinese minorities: Two case reports.

Authors:  Haifeng Liu; Yanchun Wang; Yangfang Li; Lvyan Tao; Yu Zhang; Xiaoli He; Yuantao Zhou; Xiaoning Liu; Yan Wang; Li Li
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

3.  TLR1 polymorphisms are significantly associated with the occurrence, presentation and drug-adverse reactions of tuberculosis in Western Chinese adults.

Authors:  Wu Peng; Hao Chen; Zhenzhen Zhao; Xuejiao Hu; Yi Zhou; Yingyu Li; Lian Yang; Xuemei Wang; Jiajia Song; Tangyuheng Liu; Qian Wu; Hao Bai; Xiaojun Lu; Jie Chen; Binwu Ying
Journal:  Oncotarget       Date:  2017-12-08

4.  Isoniazid-induced Immune Thrombocytopenia.

Authors:  Gaku Kuwabara; Kumiyo Tazoe; Waki Imoto; Kazushi Yamairi; Wataru Shibata; Kazuhiro Oshima; Koichi Yamada; Yasuhiro Takagi; Satoshi Shiraishi; Masayuki Hino; Tomoya Kawaguchi; Hiroshi Kakeya
Journal:  Intern Med       Date:  2021-05-29       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.